Literature DB >> 14973386

Genetically engineered mouse models of mammary intraepithelial neoplasia.

R D Cardiff1, D Moghanaki, R A Jensen.   

Abstract

Foci of atypical mammary epithelium have been associated with breast cancer in many species including mouse and man. The advent of targeted genomics has led to the creation of numerous genetically engineered mice (GEM) which display focal atypical lesions associated with mammary cancer. Some early lesions in GEM have a remarkable morphological similarity to pre-cancers in humans. While the malignant potential of atypical foci have been thoroughly documented in the non-GEM by tissue transplantation, a review of the literature reveals that precursor lesions in GEM remain incompletely described and only partially documented. Their validation as appropriate models of human breast preneoplasia awaits classical transplantation studies. Here, we review the literature characterizing early lesions of GEM models of mammary cancer, discuss the principles of the Focality, Atypia, and Association and present an introduction of mammary transplantation for model Validation.

Entities:  

Mesh:

Year:  2000        PMID: 14973386     DOI: 10.1023/a:1009534129331

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  116 in total

1.  Preneoplastic lesions in the human breast.

Authors:  H M Jensen; J R Rice; S R Wellings
Journal:  Science       Date:  1976-01-23       Impact factor: 47.728

Review 2.  Transgenic models of breast cancer metastasis.

Authors:  D L Dankort; W J Muller
Journal:  Cancer Treat Res       Date:  1996

3.  Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis.

Authors:  D M Bortner; M P Rosenberg
Journal:  Cell Growth Differ       Date:  1995-12

4.  A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.

Authors:  W P Bocchinfuso; W P Hively; J F Couse; H E Varmus; K S Korach
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

5.  p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.

Authors:  M A Shibata; I G Maroulakou; C L Jorcyk; L G Gold; J M Ward; J E Green
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

6.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

7.  Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.

Authors:  A Elson
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

8.  Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.

Authors:  T P Lin; R C Guzman; R C Osborn; G Thordarson; S Nandi
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

9.  Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.

Authors:  K F Chooi; D A Carter; S Biswas; S L Lightman; M Y Ho; D Murphy
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  28 in total

1.  Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.

Authors:  Maria I Torres-Arzayus; Jin Zhao; Roderick Bronson; Myles Brown
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

Review 2.  Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.

Authors:  Craig K Abbey; Alexander D Borowsky; Jeffery P Gregg; Robert D Cardiff; Simon R Cherry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

Review 3.  "It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.

Authors:  Matthew R Buckwalter; Pramod K Srivastava
Journal:  Semin Immunol       Date:  2008-08-20       Impact factor: 11.130

4.  Training pathologists in mouse pathology.

Authors:  J P Sundberg; J M Ward; H HogenEsch; A Yu Nikitin; P M Treuting; J B Macauley; P N Schofield
Journal:  Vet Pathol       Date:  2010-09-03       Impact factor: 2.221

Review 5.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

Review 6.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

7.  Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Authors:  Giovanni P Burrai; Sulma I Mohammed; Margaret A Miller; Vincenzo Marras; Salvatore Pirino; Maria F Addis; Sergio Uzzau; Elisabetta Antuofermo
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

8.  In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia.

Authors:  Craig K Abbey; Alexander D Borowsky; Erik T McGoldrick; Jeffrey P Gregg; Jeannie E Maglione; Robert D Cardiff; Simon R Cherry
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

Review 9.  The relevance of mouse models to understanding the development and progression of human breast cancer.

Authors:  D Craig Allred; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-14       Impact factor: 2.673

10.  Genetic mechanisms in Apc-mediated mammary tumorigenesis.

Authors:  Mari Kuraguchi; Nana Yaw Ohene-Baah; Dmitriy Sonkin; Roderick Terry Bronson; Raju Kucherlapati
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.